- Semaglutide reduced heavy drinking days vs placebo.
- Total alcohol consumption and craving decreased.
- Improvements seen in World Health Organization drinking risk levels.
- Significant weight loss and metabolic benefits observed.
- Gastrointestinal adverse events were common but mostly mild.
Source: The Lancet
